RxDoctor Payments Data

Jill Waibel, MD

Dermatology · Miami, FLNPI 1154347847

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 49 manufacturers reported payments, led by AbbVie at 25.3% of the total. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$116,409in general payments, 2019–2025

Across 456 payments — averaging $255.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$29K
  • Solta Medical, A Division Of Bausch Health US, LLC$27K
  • Eli Lilly$26K
  • Novartis$7K
  • Eli Lilly Export S.A. Puerto Rico Branch$5K
  • Lilly USA, LLC$5K
  • plus $17K from 43 others
$4,264,266in research payments, 2019–2025

Across 341 payments — averaging $12,505 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2M
  • Pfizer$414K
  • Janssen Research & Development, LLC$393K
  • Sanofi US Services Inc.$373K
  • AbbVie$350K
  • Amgen$271K
  • plus $446K from 9 others

What the payments were for

  • Consulting fees$51,96345%
  • Speaking & faculty fees$52,47545%
  • Travel & lodging$3,4113%
  • Food & beverage$8,4337%
  • Education$1280%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$116,409 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$142,737
Medicare patients
316
Services billed
1,469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate133$4,434
Desoximetasone18$2,428
ValacyclovirValacyclovir Hcl80$828
Betamethasone Dipropionate17$692
Doxycycline Hyclate93$634
Fluconazole80$333
Clobetasol Propionate14$307
Prednisone39$152
Triamcinolone Acetonide12$129
Acetaminophen-CodeineAcetaminophen With Codeine22$34

Paid to pharmacies, not to this prescriber.

Other dermatology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →